Paradigm Capital Management Inc Eton Pharmaceuticals, Inc. Transaction History
Paradigm Capital Management Inc
- $2.21 Billion
- Q3 2024
A detailed history of Paradigm Capital Management Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 300,000 shares of ETON stock, worth $3.13 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
300,000
Previous 300,000
-0.0%
Holding current value
$3.13 Million
Previous $987,000
82.37%
% of portfolio
0.08%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$29 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$10.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$10.4 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$6.45 Million0.79% of portfolio
-
Acuitas Investments, LLC580KShares$6.05 Million1.66% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $264M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...